Walden Biosciences Competitors and Similar CompaniesClear all
Walden Biosciences's competitors and similar companies include Dewpoint Therapeutics, Stablix and Kymab.
 Dewpoint Therapeutics Dewpoint Therapeutics is a company developing a platform that provides condensate drug discovery and development services. |  Stablix Stablix is a biotechnology company that specializes in the field of Targeted Protein Stabilization (TPS). |  Kymab Kymab is a biopharmaceutical company which discovers and develops human monoclonal antibody therapeutics. | ||
Founding Date | Founding Date 2020 | Founding Date 2018 | Founding Date 2021 | Founding Date 2009 |
Type | Type Private | Type Private | Type Private | Type Private |
Tags | ||||
Locations | Locations Cambridge, US HQ | Locations Boston, US HQ Dresden, DE | Locations New York, US HQ | Locations Cambridge, GB HQ |
Employees | Employees 205% decrease | Employees 1065% decrease | Employees 24 | Employees 407% decrease |
Funding | ||||
Latest funding round | Latest funding round $ 51m (over 5 years ago) | Latest funding round $ 77m (almost 6 years ago) | Latest funding round $ 63m (about 5 years ago) | Latest funding round $ 100m (over 9 years ago) |
Total funding raised | Total funding raised $ 51m | Total funding raised $ 137m | Total funding raised $ 63m | Total funding raised $ 220.4m |
For sources of this data, please see the company profile
View Company Profiles
Dewpoint Therapeutics
HQ
Boston, US
Employees
106↓ 5% decrease
Dewpoint Therapeutics is a company developing a platform that provides condensate drug discovery and development services.
View companyStablix
HQ
New York, US
Employees
24
Stablix is a biotechnology company that specializes in the field of Targeted Protein Stabilization (TPS).
View companyKymab
HQ
Cambridge, GB
Employees
40↓ 7% decrease
Kymab is a biopharmaceutical company which discovers and develops human monoclonal antibody therapeutics.
View company